
Managing Radioactive Waste
ANSTO has safely managed its radioactive waste for over 60 years. Waste is managed in accordance with national and international standards.
Showing 101 - 120 of 193 results
ANSTO has safely managed its radioactive waste for over 60 years. Waste is managed in accordance with national and international standards.
ANSTO is a partner on the National Space Qualification Network (NSQN) led by the Australian National University (ANU) that will transform Australia into a world-leading space centre by enhancing facilities to test payloads, components, and hardware prior to their use in harsh environments of space.
ANSTO researchers have taken up the challenge to develop a coating for the cladding used in nuclear reactors to prevent it from taking up hydrogen and releasing it if temperatures get too high and repair itself if damaged.
An accomplished international photographer has capture dazzling new images of one component of the main ring at our Australian Synchrotron and provided an inside view of the electron’s path when it is used.
Dr Anna Paradowska has been appointed as a Conjoint Professor of Practice in Advanced Structural Materials at the University of Sydney.
ANSTO has just completed the largest coordinated safety and security review of the OPAL multi-purpose research reactor, as part of a new a world-leading approach to assessing performance
MABI instrument can determine both the concentration and source of black carbon pollution in the atmosphere.
Tool developed for producing F-18 radiopharmaceuticals for PET imaging.
ANSTO announces the recipients of the 2022 organisational awards
Australia and Sri Lanks signs new partnership to fight chronic kidney disease.
Research has demonstrated that internally generated neutrons could be used to effectively target micro-infiltrates and cancer cells outside of the defined treatment regions.
The International Synchrotron Access Program (ISAP) is administered by the Australian Synchrotron and is designed to assist Australian-based synchrotron users to access overseas synchrotron related facilities.
Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australia’s first GMP (Good Manufacturing Practice) theranostics facility starting in Melbourne, Australia.
Australian researchers and clinicians have recently returned from Japan where they investigated the use of advanced radiation therapy for cancer using heavy ions at particle therapy facilities on a study tour .
ANSTO's Chief Nuclear Officer shares insights on the safe management of Australia's nuclear waste.